产品名称
抗RNA聚合酶II亚基B1(磷酸化CTD Ser-7)抗体,克隆4E12, clone 4E12, from rat
biological source
rat
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
4E12, monoclonal
species reactivity
mouse
species reactivity (predicted by homology)
human (based on 100% sequence homology)
technique(s)
ChIP: suitable
ELISA: suitable
western blot: suitable
isotype
IgG1κ
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
phosphorylation (pSer7)
Quality Level
Gene Information
human ... POLR2B(5431)
Analysis Note
对照
γ-蛋白磷酸酶(γ-PPase)未处理和处理的NIH/3T3细胞裂解液
γ-蛋白磷酸酶(γ-PPase)未处理和处理的NIH/3T3细胞裂解液
已通过蛋白质印迹在未经处理和经γ-PPase处理的NIH/3T3细胞裂解液中进行了评估。
蛋白质印迹分析:0.25 µg/ml该抗体在10 µg γ-PPase未处理和处理的NIH/3T3细胞裂解液上检测到RNA聚合酶II CTD。
蛋白质印迹分析:0.25 µg/ml该抗体在10 µg γ-PPase未处理和处理的NIH/3T3细胞裂解液上检测到RNA聚合酶II CTD。
Application
抗RNA聚合酶II亚基B1(磷酸化-CTD Ser-7)抗体,克隆4E12是用于检测RNA聚合酶II亚基B1(磷酸化-CTD Ser-7)的大鼠单克隆抗体,已在WB,ELISA中进行了验证。
染色质免疫沉淀分析: 代表性批次已被独立实验室用于ChIP。(Chapman, R., et al. (2007).Science.318(5857):1780 -1782.)
研究子类别
转录因子
RNA代谢 & 结合蛋白
转录因子
RNA代谢 & 结合蛋白
研究类别
表观遗传学 & 核功能
表观遗传学 & 核功能
表观遗传学 & 核功能
表观遗传学 & 核功能
Biochem/physiol Actions
该抗体可识别CTD处Ser7磷酸化的RNA聚合酶II亚基B1。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
General description
RNA聚合酶II亚基B1(RPB1)是RNA聚合酶II复合物中最大的亚基。作为全酶RNA聚合酶II使用四种核糖核苷三磷酸作为底物,催化真核DNA转录为RNA。RBP1亚基与其他聚合酶亚基结合形成一个大的中央裂口,该裂口保持酶的活性位点,DNA模板和新生的RNA转录本之间的接触。该亚基还包含由串联七肽重复序列组成的羧基末端结构域(CTD)。磷酸化激活RNA聚合酶IIβ亚基,使其可以作为调节起始,延伸,终止和mRNA加工的其他亚基的组装平台。在主动转录RNA聚合酶中,七肽重复序列的‘Ser-2’和‘Ser-5’被磷酸化。Ser-7在启动子区域开始转录之前被磷酸化。
~220 kDa
Immunogen
与Ser7磷酸化的人RNA聚合酶亚基B1 CTD对应的卵清蛋白偶联线性肽。
表位:Ser7
Other Notes
浓度:请参考批次特异性浓缩物的检验报告。
Physical form
形式:纯化
纯化的大鼠单克隆IgG1κ溶于含0.1 M Tris-甘氨酸(pH 7.4),150 mM NaCl和0.05%叠氮化钠的缓冲液中。
蛋白G纯化
Preparation Note
自收到之日起,在2-8°C条件下可稳定保存1年。
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Tianlu Huang et al.
Cell death & disease, 10(8), 602-602 (2019-08-11)
Cholangiocarcinoma (CCA) is a fatal disease without effective targeted therapy. We screened a small-molecule library of 116 inhibitors targeting different targets of the cell cycle and discovered several kinases, including Cyclin-dependent kinase 7 (CDK7) as vulnerabilities in CCA. Analysis of
Ana M Sanchez et al.
Nucleic acids research, 48(9), 4811-4826 (2020-04-14)
The phosphorylation pattern of Pol2 CTD Y1S2P3T4S5P6S7 repeats comprises an informational code coordinating transcription and RNA processing. cis-trans isomerization of CTD prolines expands the scope of the code in ways that are not well understood. Here we address this issue
Gregory T Booth et al.
Nature communications, 9(1), 543-543 (2018-02-09)
Post-translational modifications of the transcription elongation complex provide mechanisms to fine-tune gene expression, yet their specific impacts on RNA polymerase II regulation remain difficult to ascertain. Here, in Schizosaccharomyces pombe, we examine the role of Cdk9, and related Mcs6/Cdk7 and
Chao Han et al.
PloS one, 15(11), e0240801-e0240801 (2020-11-03)
Our previously study shown that Lysophosphatidylcholine Acyltransferase1 (LPCAT1) is overexpressed in castration resistant prostate cancer (CRPC) relative to primary prostate cancer (PCa), and androgen controls its expression via the Wnt signaling pathway. While highly expressed in CRPC, the role of
Emily Brookes et al.
Cell stem cell, 10(2), 157-170 (2012-02-07)
Polycomb repressor complexes (PRCs) are important chromatin modifiers fundamentally implicated in pluripotency and cancer. Polycomb silencing in embryonic stem cells (ESCs) can be accompanied by active chromatin and primed RNA polymerase II (RNAPII), but the relationship between PRCs and RNAPII
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持